Table 1.
Clinical characteristics of study subjects.
| Characteristics | TAV-NA | BAV-NA | TAV-A | BAV-A |
|---|---|---|---|---|
| Number (female) | 15 (5) | 10 (2) | 14 (6) | 29 (5) |
| Age (y) | 66 ± 23 | 47 ± 13b | 69 ± 13 | 59 ± 15 |
| Hypertension, n (%) | 4 (40)a | 2 (20) | 10 (71) | 18 (62) |
| Diabetes, n (%) | 5 (50)a | 2 (20) | 2 (14) | 2 (7) |
| Smoking, n (%) | 4 (40)a | 6 (60) | 4 (29) | 10 (35) |
| Aortic stenosis n (%) | 0 (0)a | 5 (50) | 0 (0) | 16 (55) |
| Aortic regurgitation | 0 (0)a | 5 (50) | 4 (29) | 17 (59) |
| Maximum Ascending Aorta Diameter (cm) | 3.2 ± 0.4 | 3.7 ± 0.4 | 5.3 ± 0.8c | 5.1 ± 0.5c |
| Maximum Ascending Aorta Diameter (cm/m2) | 1.9 ± 0.3 | 1.9 ± 0.3 | 2.7 ± 0.4c | 2.6 ± 0.3c |
a
n = 10.
b
P = .049 vs TAV-NA.
c
P < .0001 vs TAV-NA and BAV-NA.